Previous Close | 1.8500 |
Open | 1.8000 |
Bid | 1.7500 |
Ask | 1.8400 |
Strike | 55.00 |
Expire Date | 2025-01-17 |
Day's Range | 1.7300 - 1.8200 |
Contract Range | N/A |
Volume | |
Open Interest | 2.26k |
Gilead stock pared its gains Friday after beating first-quarter sales forecasts on the back of its Covid treatment, Veklury.
Gilead (GILD) reports narrower-than-expected loss in the first quarter. Its sales beat estimates on higher HIV, Oncology and Liver Disease sales.
Q1 2024 Gilead Sciences Inc Earnings Call